- Half Year 2023 Imricor Medical Systems Inc Earnings Call TranscriptAug 23, 2023A$0.658536 (-8.72%)Earnings
- Imricor Medical Systems Inc Ordinary Shareholders Meeting TranscriptMay 11, 2023
- Imricor Medical Systems Inc Extraordinary Shareholders Meeting TranscriptMar 06, 2023
- Full Year 2022 Imricor Medical Systems Inc Earnings Call TranscriptFeb 22, 2023A$0.309899 (+1.59%)Earnings
- Imricor Medical Systems Inc Virtual Open House and Business Overview Call TranscriptNov 18, 2022
- Q3 2022 Imricor Medical Systems Inc Earnings Call TranscriptOct 26, 2022A$0.251793Earnings
- Half Year 2022 Imricor Medical Systems Inc Earnings Call TranscriptAug 30, 2022A$0.363163 (+8.70%)Earnings
- Q4 2022 Imricor Medical Systems Inc Earnings Call TranscriptJul 27, 2022A$0.300215Earnings
- Imricor Medical Systems Inc Annual Shareholders Meeting TranscriptMay 03, 2022
- Q4 2021 Imricor Medical Systems Inc Earnings Call TranscriptFeb 23, 2022A$0.774748 (-1.23%)Earnings
- Q4 2022 Imricor Medical Systems Inc Cashflow Reports Call TranscriptJan 26, 2022
- Half Year 2021 Imricor Medical Systems Inc Earnings Call TranscriptAug 25, 2021A$1.19 (-1.99%)Earnings
- Imricor Medical Systems Inc Annual Shareholders Meeting TranscriptMay 05, 2021
- Full Year 2020 Imricor Medical Systems Inc Earnings Call TranscriptFeb 24, 2021A$2.19 (+2.73%)Earnings
- Q4 2020 Imricor Medical Systems Inc Earnings Call TranscriptJan 27, 2021A$2.31 (+0.84%)Earnings
- Half Year 2020 Imricor Medical Systems Inc Earnings Call TranscriptAug 24, 2020A$1.57 (-4.71%)Earnings
- Q4 2020 Imricor Medical Systems Inc Cashflow Reports Call TranscriptJul 28, 2020
- Imricor Medical Systems Inc Annual Shareholders Meeting TranscriptMay 12, 2020
- Q4 2019 Imricor Medical Systems Inc Earnings Call TranscriptJan 29, 2020A$1.41 (+7.35%)Earnings
Q4 2022 Imricor Medical Systems Inc Earnings Call Transcript
Good morning, and welcome to Imricor's quarterly investor webinar for the period ending 30th June 2022. On the webinar today, we have the founder and CEO, Steve Wedan, and the company's CFO, Jonathon Gus. Before I hand it over to the guys to get started and go through a brief presentation, I'll just remind you that you can ask questions through the Q&A panel at the bottom of the screen. We'll get to those post the brief presentation.
Steve, Jonathon, I'll now hand it over to you to get started. Thanks very much.
Thank you, Simon. Check that I'm off mute. Yes. Thanks, everyone, for joining us today, this morning. Imricor released its Appendix 4C for the second quarter of 2022, and we'd like to discuss these results as well as provide a general business update. So Jon will begin by presenting the quarterly cash flow results. Jon?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)